Atara Biotherapeutics, Inc. (LON:0HIY)

Atara Biotherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	63	61	41	258	1,029	1,191
Market Cap Growth	69.65%	49.24%	-84.11%	-74.90%	-13.57%	76.82%
Enterprise Value	59	47	9	102	783	961
Last Close Price	8.39	10.42	11.43	66.91	309.26	476.45
PS Ratio	0.46	0.60	6.10	4.89	68.51	-
PB Ratio	-2.46	-0.79	-0.53	2.46	4.98	3.52
P/TBV Ratio	-	-	-	2.46	4.98	3.52
EV/Sales Ratio	0.41	0.46	1.36	1.93	52.15	-
Debt / Equity Ratio	-0.50	-0.47	-0.58	0.57	0.10	0.03
Asset Turnover	2.45	0.94	0.03	0.15	0.04	-
Inventory Turnover	-	16.58	40.39	-	-	-
Quick Ratio	1.53	0.33	0.60	3.60	3.53	6.06
Current Ratio	1.70	0.48	0.72	3.74	3.64	6.31
Return on Equity (ROE)	-	-	-2014.86%	-112.39%	-91.69%	-81.43%
Return on Assets (ROA)	15.71%	-35.66%	-62.11%	-40.63%	-40.29%	-41.49%
Return on Capital (ROIC)	-	-	-214.41%	-67.79%	-54.20%	-49.28%
Earnings Yield	6.71%	-111.40%	-528.31%	-73.36%	-24.41%	-18.86%
FCF Yield	-74.15%	-89.96%	-371.56%	-88.25%	-16.59%	-11.40%
Buyback Yield / Dilution	-103.16%	-76.77%	-3.83%	-8.88%	-26.63%	-44.17%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.